119 related articles for article (PubMed ID: 8535416)
1. Application of curdlan to controlled drug delivery. III. Drug release from sustained release suppositories in vitro.
Kanke M; Tanabe E; Katayama H; Koda Y; Yoshitomi H
Biol Pharm Bull; 1995 Aug; 18(8):1154-8. PubMed ID: 8535416
[TBL] [Abstract][Full Text] [Related]
2. Application of curdlan to controlled drug delivery. I. The preparation and evaluation of theophylline-containing curdlan tablets.
Kanke M; Koda K; Koda Y; Katayama H
Pharm Res; 1992 Mar; 9(3):414-8. PubMed ID: 1614977
[TBL] [Abstract][Full Text] [Related]
3. Indomethacin sustained-release suppositories containing sugar ester.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1990 Apr; 38(4):1027-31. PubMed ID: 2379274
[TBL] [Abstract][Full Text] [Related]
4. Thermal gelation of aqueous curdlan suspension: preparation of curdlan jelly.
Hino T; Ishimoto H; Shimabayashi S
J Pharm Pharmacol; 2003 Apr; 55(4):435-41. PubMed ID: 12803764
[TBL] [Abstract][Full Text] [Related]
5. Indomethacin sustained-release suppositories containing sugar ester in polyethylene glycol base.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1680-3. PubMed ID: 2208382
[TBL] [Abstract][Full Text] [Related]
6. Thermally reversible xyloglucan gels as vehicles for rectal drug delivery.
Miyazaki S; Suisha F; Kawasaki N; Shirakawa M; Yamatoya K; Attwood D
J Control Release; 1998 Dec; 56(1-3):75-83. PubMed ID: 9801431
[TBL] [Abstract][Full Text] [Related]
7. In vitro drug liberation and kinetics of sustained release indomethacin suppository.
Uzunkaya G; Bergişadi N
Farmaco; 2003 Jul; 58(7):509-12. PubMed ID: 12818689
[TBL] [Abstract][Full Text] [Related]
8. Preparation and in vitro evaluation of sustained-release suppositories containing microencapsulated indomethacin.
Nakajima T; Takashima Y; Iida K; Mitsuta H; Koishi M
Chem Pharm Bull (Tokyo); 1987 Mar; 35(3):1201-6. PubMed ID: 3607943
[No Abstract] [Full Text] [Related]
9. Novel chronotherapeutic rectal aminophylline delivery system for therapy of asthma.
Shiohira H; Fujii M; Koizumi N; Kondoh M; Watanabe Y
Int J Pharm; 2009 Sep; 379(1):119-24. PubMed ID: 19555748
[TBL] [Abstract][Full Text] [Related]
10. [Controlled release of prednisolone from suppository prepared using powder of pulverized tablet].
Tatsumi A; Oda S; Nakamoto T; Muraoka R; Takahashi Y; Tanaka K; Shikata T; Tatsumi S; Tagawa N; Kobayashi Y; Hamaguchi T; Kadobayashi M
Yakugaku Zasshi; 2008 Apr; 128(4):641-8. PubMed ID: 18379182
[TBL] [Abstract][Full Text] [Related]
11. Study on absorption of indomethacin from sustained-release suppositories containing hydrogenated soybean lecithin in rabbits.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3145-7. PubMed ID: 2632063
[TBL] [Abstract][Full Text] [Related]
12. Self-assembled hydrogel nanoparticles from curdlan derivatives: characterization, anti-cancer drug release and interaction with a hepatoma cell line (HepG2).
Na K; Park KH; Kim SW; Bae YH
J Control Release; 2000 Nov; 69(2):225-36. PubMed ID: 11064130
[TBL] [Abstract][Full Text] [Related]
13. Preparation of sustained-release suppositories containing microencapsulated indomethacin and bioavailability of indomethacin in rabbits.
Nakajima T; Takashima Y; Iida K; Mitsuta H; Furuya A; Koishi M
Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4249-54. PubMed ID: 3435949
[No Abstract] [Full Text] [Related]
14. Application of curdlan to controlled drug delivery. II. In vitro and in vivo drug release studies of theophylline-containing curdlan tablets.
Kanke M; Katayama H; Nakamura M
Biol Pharm Bull; 1995 Aug; 18(8):1104-8. PubMed ID: 8535404
[TBL] [Abstract][Full Text] [Related]
15. The role of various surfactants on the release of salbutamol from suppositories.
Hanaee J; Javadzadeh Y; Taftachi S; Farid D; Nokhodchi A
Farmaco; 2004 Nov; 59(11):903-6. PubMed ID: 15544795
[TBL] [Abstract][Full Text] [Related]
16. Sustained release indomethacin: a double blind comparison with indomethacin suppositories.
Iversen O; Fowles M; Vlieg M; Smidt N; Wigley R
N Z Med J; 1981 Apr; 93(682):261-2. PubMed ID: 7019782
[TBL] [Abstract][Full Text] [Related]
17. Studies on sustained-release dosage forms. I. Preparation and bioavailability of indomethacin suppositories.
Umeda T; Matsuzawa A; Yokoyama T; Kuroda K; Kuroda T
Chem Pharm Bull (Tokyo); 1983 Aug; 31(8):2793-8. PubMed ID: 6652823
[No Abstract] [Full Text] [Related]
18. Preparation of sustained-release suppositories of indomethacin using a solid dispersion system and evaluation of bioavailability in rabbits.
Ohnishi N; Yokoyama T; Umeda T; Kiyohara Y; Kuroda T; Kita Y; Kuroda K
Chem Pharm Bull (Tokyo); 1986 Jul; 34(7):2999-3004. PubMed ID: 3769103
[No Abstract] [Full Text] [Related]
19. Evaluation of sustained release suppositories prepared with fatty base including solid fats with high melting points.
Takatori T; Shimono N; Higaki K; Kimura T
Int J Pharm; 2004 Jul; 278(2):275-82. PubMed ID: 15196632
[TBL] [Abstract][Full Text] [Related]
20. Design of controlled-release morphine suppositories containing polyglycerol ester of fatty acid.
Takatori T; Yamamoto K; Yamaguchi T; Higaki K; Kimura T
Biol Pharm Bull; 2005 Aug; 28(8):1480-4. PubMed ID: 16079497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
